Dossier
cisplatin
Coverage of cisplatin in the Nexus archive.
- Pricing delay raises shortage of medicine, counterfeiting risks
A delay in approving price revisions for 105 essential medicines in Pakistan has led to shortages and increased risks of counterfeit drugs. Manufacturers cite rising production costs and financial unsustainability, while experts warn of supply chain integrity threats as illegal suppliers fill the gap.